Nesidioblastosis following laparoscopic sleeve gastrectomy

Clin Endocrinol (Oxf). 2019 Dec;91(6):906-908. doi: 10.1111/cen.14083. Epub 2019 Oct 14.

Authors

Albert Kim^{1

2}, Jennifer R Snaith^{1

2}, Hema Mahajan^{2

3

4}, Deborah Jane Holmes-Walker^{1

2}

Affiliations

¹ Department of Diabetes and Endocrinology, Westmead Hospital, Westmead, NSW, Australia.
² Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
³ Tissue Pathology, Institute for Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia.
⁴ School of Medicine, University of Western Sydney, Campbelltown, NSW, Australia.

PMID: 31465534
DOI: 10.1111/cen.14083

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Diazoxide / therapeutic use
Female
Gastrectomy / adverse effects*
Humans
Middle Aged
Nesidioblastosis / diagnosis*
Nesidioblastosis / drug therapy
Nesidioblastosis / etiology

Substances

Diazoxide